• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Anticipating Advances for Pediatric Vitiligo

Key Takeaways

  • Targeted biologics and JAK inhibitors show promise in modulating immune responses and promoting repigmentation in pediatric vitiligo.
  • Advancements in phototherapy and laser treatments offer improved efficacy and safety profiles for children with vitiligo.
SHOW MORE

The panelist discusses advances in targeted therapies, including novel biologics and small molecules, as well as the development of personalized treatment approaches tailored to individual patient characteristics, which hold great promise for improving outcomes and enhancing the quality of life for children living with vitiligo in the future.

Video Player is loading.
Current Time 0:00
Duration 1:53
Loaded: 0%
Stream Type LIVE
Remaining Time 1:53
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Video content above is prompted by the following:

    • What advances in research or new therapies do you believe hold the most promise for improving outcomes in pediatric vitiligo treatment?
    • How do you envision the future of vitiligo management for children, particularly in the context of personalized medicine and innovative treatment strategies?
    © 2025 MJH Life Sciences

    All rights reserved.